AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10674280 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 0
Study 9342764 — intervention group
Group type: EXPERIMENTAL
Intervention: LI 160 (900 mg total daily dose)
Number of subjects: 0
Study 9342764 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (75 mg total daily dose)
Number of subjects: 0
Study 9342764 — intervention group
Group type: EXPERIMENTAL
Intervention: LI 160
Number of subjects: 0
Study 9342764 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 8213020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical epidural steroid/lidocaine injections (group A)
Number of subjects: 50
Study 8213020 — intervention group
Group type: COMPARATOR
Intervention: Steroid/lidocaine injections into the posterior neck muscles (group B)
Number of subjects: 50
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 2 mg/l
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at various concentrations (0.015 to 0.06 mg/l)
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 2-4 mg/l
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 16 mg/l
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 32 mg/l
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 1.0 mg/l or more for 120 h
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 4 mg/l
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin at 40 mg/l
Number of subjects: 750
Study 3924877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% mupirocin topical treatment
Number of subjects: 750
Study 31121030 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise intervention for 3 months
Number of subjects: 143
Study 31121030 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study 29678970 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote care group (n=30) received care remotely for 6 months incorporating: home hearing in noise test, online support tool and self‐adjustment of device
Number of subjects: 60
Study 29678970 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=30) followed usual care pathway
Number of subjects: 60
Study 29678970 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote care group (n=30)
Number of subjects: 60
Study 29678970 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 60
Study 26579847 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC D-Blade
Number of subjects: 1100
Study 26579847 — intervention group
Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 1100
Study 26579847 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 1100
Study 23677131 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of simvastatin (n=40)
Number of subjects: 79
Study 23677131 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=39)
Number of subjects: 79
Study 21715526 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-nut dose (75 g/day mixed nuts)
Number of subjects: 117
Study 21715526 — intervention group
Group type: COMPARATOR
Intervention: Half-nut dose
Number of subjects: 117
Study 21715526 — intervention group
Group type: COMPARATOR
Intervention: Muffin
Number of subjects: 117
Study 19302259 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine infusion (40 microg kg(‐1) min(‐1))
Number of subjects: 16
Study 19302259 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 17507344 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-kcal/kg per week exercise group
Number of subjects: 464
Study 17507344 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-kcal/kg per week exercise group
Number of subjects: 464
Study 17507344 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-kcal/kg per week exercise group
Number of subjects: 464
Study 17507344 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 464
Study 15509083 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular brushing with dentifrices
Number of subjects: 150
Study 15509083 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of toothbrushes and dentifrice
Number of subjects: 150
Study 11548915 — intervention group
Group type: EXPERIMENTAL
Intervention: Torso immersion in cool water
Number of subjects: 5
Study 11548915 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands and feet immersion in cool water
Number of subjects: 5
Study 11548915 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit in shade with a 1.5mph breeze
Number of subjects: 5
Study 11548915 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean heart rate readings
Number of subjects: 5
Study 9271287 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced brisk walking
Number of subjects: 165
Study 9271287 — intervention group
Group type: COMPARATOR
Intervention: Upper limb exercises (placebo)
Number of subjects: 165
Study 24234326 — intervention group
Group type: EXPERIMENTAL
Intervention: Work-oriented physical fitness course
Number of subjects: 148
Study 24234326 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 148
Study 3067745 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobunolol
Number of subjects: 51
Study 3067745 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% levobunolol
Number of subjects: 51
Study 3067745 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol
Number of subjects: 51
Study 378735 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (1 g 8-hourly orally for fourteen days)
Number of subjects: 62
Study 378735 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 62
Study 31548149 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteotome
Number of subjects: 10
Study 31548149 — intervention group
Group type: COMPARATOR
Intervention: Saw
Number of subjects: 10
Study 30390234 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole 60 mg once daily (QD) during open-label healing phase
Number of subjects: 62
Study 30390234 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole 30 mg QD during double-blind maintenance phase
Number of subjects: 62
Study 30390234 — intervention group
Group type: COMPARATOR
Intervention: Placebo during double-blind maintenance phase
Number of subjects: 62
Study 30390234 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole 60 mg QD
Number of subjects: 62
Study 30390234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 28478635 — intervention group
Group type: EXPERIMENTAL
Intervention: DuraMax® (DM)
Number of subjects: 86
Study 28478635 — intervention group
Group type: COMPARATOR
Intervention: SplitCath® (SC)
Number of subjects: 86
Study 25622239 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone Duphaston(®) (2× 10mg) administered two times daily
Number of subjects: 853
Study 25622239 — intervention group
Group type: COMPARATOR
Intervention: Crinone 8%(®) vaginal progesterone gel (90mg) administered daily
Number of subjects: 853
Study 25622239 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone Duphaston(®)
Number of subjects: 853
Study 25622239 — intervention group
Group type: COMPARATOR
Intervention: Crinone 8%(®) vaginal progesterone gel
Number of subjects: 853
Study 23876455 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT+ART
Number of subjects: 77
Study 23876455 — intervention group
Group type: COMPARATOR
Intervention: CBT+HLS
Number of subjects: 77
Study 21337584 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation with fasting, water, laxatives, and antiflatulents (Group I)
Number of subjects: 611
Study 21337584 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation with fasting, water, and antiflatulents alone (Group II)
Number of subjects: 611
Study 21337584 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation with fasting and water alone (Group III)
Number of subjects: 611
Study 20016175 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum
Number of subjects: 204
Study 20016175 — intervention group
Group type: COMPARATOR
Intervention: Control group (no xylitol)
Number of subjects: 204
Study 17550213 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 37
Study 17550213 — intervention group
Group type: COMPARATOR
Intervention: Nontreated patients
Number of subjects: 37
Study 15048662 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatments for weight loss
Number of subjects: 120
Study 15048662 — intervention group
Group type: COMPARATOR
Intervention: C/C subjects in the obesity trial
Number of subjects: 120
Study 11493210 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative gastric aspiration with an orogastric tube
Number of subjects: 74
Study 11493210 — intervention group
Group type: COMPARATOR
Intervention: Control group (no gastric aspiration)
Number of subjects: 74
Study 11493210 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative gastric aspiration
Number of subjects: 74
Study 9566644 — intervention group
Group type: EXPERIMENTAL
Intervention: T4 or T3 treatment for six months
Number of subjects: 24
Study 9566644 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 24
Study 7827931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of the trunks of the inferior thyroid arteries
Number of subjects: 100
Study 7827931 — intervention group
Group type: COMPARATOR
Intervention: Suture-ligation of the branches of the inferior thyroid arteries at the thyroid capsule
Number of subjects: 100
Study 2457767 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-human atrial natriuretic peptide (alpha-hANP) infusion for 30 min
Number of subjects: 11
Study 31276190 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (0.2 mg/kg)
Number of subjects: 250
Study 31276190 — intervention group
Group type: COMPARATOR
Intervention: Morphine (0.2 mg/kg)
Number of subjects: 250
Study 28419890 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Navigation (N+)
Number of subjects: 614
Study 28419890 — intervention group
Group type: COMPARATOR
Intervention: Navigation as Usual (NAU)
Number of subjects: 614
Study 25645373 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma ventral capsulotomy (GVC)
Number of subjects: 16
Study 25645373 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 16
Study 24579274 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofilled-resin composite with glass-fiber layering (FRC)
Number of subjects: 47
Study 24579274 — intervention group
Group type: COMPARATOR
Intervention: Nanofilled-resin composite without glass-fiber layering (RC)
Number of subjects: 47
Study 24579274 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FRC and RC
Number of subjects: 47
Study 21475254 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-based motivational protocol for smoking cessation advice and support
Number of subjects: 0
Study 21475254 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on smoking and oral health, vocational training on motivational interviewing, structured advice protocols
Number of subjects: 0
Study 18341680 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-enhancing dietary supplement (DS) with 21 mg synephrine and 304 mg caffeine
Number of subjects: 10
Study 18341680 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 10
Study 17947933 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg/kg fructose-1,6-diphosphate (FDP)
Number of subjects: 38
Study 17947933 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mM (1.4 g/L) fructose-1,6-diphosphate (FDP)
Number of subjects: 38
Study 17947933 — intervention group
Group type: COMPARATOR
Intervention: 5% dextrose (control)
Number of subjects: 38
Study 14735348 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expanding metallic stent placement
Number of subjects: 30
Study 14735348 — intervention group
Group type: COMPARATOR
Intervention: Stoma creation
Number of subjects: 30
Study 11292009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (30 mg/70 kg) at infusion rates of 2, 15, and 60 seconds
Number of subjects: 12
Study 11292009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydromorphone (3 mg/70 kg) at infusion rates of 2, 15, and 60 seconds
Number of subjects: 12
Study 11292009 — intervention group
Group type: COMPARATOR
Intervention: Placebo at infusion rates of 2, 15, and 60 seconds
Number of subjects: 12
Study 9313398 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support intervention
Number of subjects: 363
Study 9313398 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 363
Study 9313398 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined social support and education intervention
Number of subjects: 363
Study 9313398 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 363
Study 8198308 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg pseudoephedrine
Number of subjects: 250
Study 8198308 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 3654236 — intervention group
Group type: EXPERIMENTAL
Intervention: Living with Asthma (LWA) program
Number of subjects: 400
Study 3654236 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Airways (OA) program
Number of subjects: 400
Study 3654236 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-participants)
Number of subjects: 400
Study 30464449 — intervention group
Group type: EXPERIMENTAL
Intervention: ICS/LABA
Number of subjects: 0
Study 30464449 — intervention group
Group type: COMPARATOR
Intervention: LABA alone
Number of subjects: 0
Study 28481890 — intervention group
Group type: EXPERIMENTAL
Intervention: Soil-transmitted helminth infection
Number of subjects: 835
Study 28481890 — intervention group
Group type: COMPARATOR
Intervention: No soil-transmitted helminth infection
Number of subjects: 835
Study 28481890 — intervention group
Group type: EXPERIMENTAL
Intervention: Low shuttle run performance
Number of subjects: 835
Study 26092649 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT, 2×/wk)
Number of subjects: 38
Study 26092649 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump Training (JUMP, 3×/wk)
Number of subjects: 38
Study 26092649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RT and JUMP
Number of subjects: 38
Study 23561068 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate pressure massage therapy
Number of subjects: 42
Study 23561068 — intervention group
Group type: COMPARATOR
Intervention: Light pressure massage therapy
Number of subjects: 42
Study 21937367 — intervention group
Group type: COMPARATOR
Intervention: Standard triple treatment plus probiotic (lansoprazole, clarithromycin, amoxicillin, saccharomyces boulardii)
Number of subjects: 285
Study 21937367 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin-based therapy (esomeprazole, levofloxacin, amoxicillin for 14 days)
Number of subjects: 285
Study 21937367 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin-based triple therapy (esomeprazole and amoxicillin for 5 days, followed by esomeprazole, levofloxacin, and metronidazole for 7 days)
Number of subjects: 285
Study 18677055 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention for osteoporosis
Number of subjects: 0
Study 18677055 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific protocols of exercises
Number of subjects: 0
Study 16850448 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal suction (NPS) specimens
Number of subjects: 47
Study 16850448 — intervention group
Group type: COMPARATOR
Intervention: Throat swabs
Number of subjects: 47
Study 12701116 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) at a dose of 2,400 mg per day
Number of subjects: 21
Study 12701116 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 21
Study 10939036 — intervention group
Group type: EXPERIMENTAL
Intervention: Theodrip (theophylline) 4.8 mg/kg
Number of subjects: 9
Study 10939036 — intervention group
Group type: COMPARATOR
Intervention: Theodrip (theophylline)
Number of subjects: 9
Study 10939036 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline
Number of subjects: 9
Study 8627041 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V)
Number of subjects: 0
Study 8627041 — intervention group
Group type: COMPARATOR
Intervention: Measles-mumps-rubella and varicella vaccines at separate injection sites
Number of subjects: 0
Study 1357306 — intervention group
Group type: EXPERIMENTAL
Intervention: Case finding and surveillance intervention by a specially appointed nurse after a postal questionnaire.
Number of subjects: 369
Study 1357306 — intervention group
Group type: COMPARATOR
Intervention: Control group with no questionnaires and no contact with the nurse.
Number of subjects: 369
Study 2415097 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino-oxyacetic acid (50 or 75 mg, four times a day orally for one week)
Number of subjects: 10
Study 2415097 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino-oxyacetic acid
Number of subjects: 10
Study 2415097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30958514 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness yoga
Number of subjects: 187
Study 30958514 — intervention group
Group type: COMPARATOR
Intervention: Stretching and Resistance Training Exercises (SRTE)
Number of subjects: 187
Study 30027921 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary technique
Number of subjects: 95
Study 30027921 — intervention group
Group type: COMPARATOR
Intervention: Manual step-back technique
Number of subjects: 95
Study 27935977 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based sodium reduction program with reduced-sodium, added-potassium salt substitute and health education program
Number of subjects: 1903
Study 27935977 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based sodium reduction program
Number of subjects: 1903
Study 27935977 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1903
Study 25440382 — intervention group
Group type: COMPARATOR
Intervention: Acupressure wristbands
Number of subjects: 26
Study 25440382 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (placebo)
Number of subjects: 26
Study 22606978 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (Gp‐L)
Number of subjects: 120
Study 22606978 — intervention group
Group type: COMPARATOR
Intervention: No lactulose (Gp‐NL)
Number of subjects: 120
Study 22606978 — intervention group
Group type: EXPERIMENTAL
Intervention: CFF (Critical Flicker Frequency)
Number of subjects: 120
Study 20091824 — intervention group
Group type: EXPERIMENTAL
Intervention: QuBE score
Number of subjects: 284
Study 17980550 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (10mg/day to start, dose elevation of 10mg/week up to 50mg/day if tolerated for eight weeks)
Number of subjects: 44
Study 17980550 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 44
Study 16135924 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone
Number of subjects: 61
Study 16135924 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 11809988 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention including a pre-school asthma booklet, a written guided self-management plan, and two 20-minute structured educational sessions with a specialist respiratory nurse.
Number of subjects: 200
Study 11809988 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 200
Study 11809988 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention.
Number of subjects: 200
Study 10523008 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg TU
Number of subjects: 32
Study 10523008 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg TU
Number of subjects: 32
Study 10523008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 10523008 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg TU and 1000 mg TU
Number of subjects: 32
Study 7491882 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g honey
Number of subjects: 20
Study 7491882 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g honey
Number of subjects: 20
Study 7491882 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-fructose mixture (35 g each)
Number of subjects: 20
Study 7491882 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g lactulose
Number of subjects: 20
Study 1773906 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 micrograms/kg prostaglandin E1
Number of subjects: 30
Study 1773906 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 micrograms/kg prostaglandin E1
Number of subjects: 30
Study 1773906 — intervention group
Group type: COMPARATOR
Intervention: saline (group A)
Number of subjects: 30
Study 6176313 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (5‐FU and methyl‐CCNU)
Number of subjects: 90
Study 6176313 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality therapy (external radiotherapy of 5000 rad combined with chemotherapy)
Number of subjects: 90
Study 30304958 — intervention group
Group type: EXPERIMENTAL
Intervention: PNF stretching combined with a structured exercise programme (two days per week for six weeks)
Number of subjects: 40
Study 30304958 — intervention group
Group type: COMPARATOR
Intervention: Static stretching combined with a structured exercise programme (two days per week for six weeks)
Number of subjects: 40
Study 29772642 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium bicarbonate (KHCO₃) 90 mmol∙day‐1
Number of subjects: 16
Study 29772642 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 16
Study 26934216 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed pregnancy record booklet
Number of subjects: 56
Study 24565386 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 75
Study 24565386 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetrone 4 mg
Number of subjects: 75